Literature DB >> 28923852

TET-Mediated Sequestration of miR-26 Drives EZH2 Expression and Gastric Carcinogenesis.

Min Deng1, Ruixin Zhang2, Zhengxi He3, Qinwei Qiu2, Xihong Lu4, Jiang Yin2, Hao Liu2, Xiaoting Jia2, Zhimin He1.   

Abstract

DNA demethylases of the TET family function as tumor suppressors in various human cancers, but their pathogenic contributions and mechanisms of action in gastric carcinogenesis and progression remain unclear. Here, we report that TET is transcriptionally upregulated in gastric cancer, where it correlates with poor prognosis. Mechanistic investigations revealed that TET facilitated gastric carcinogenesis through a noncoding function of the 3'UTR, which interacted with miR-26. This interaction resulted in sequestration of miR-26 from its target EZH2, which released the suppression on EZH2, and thereby led to EZH2 overexpression in gastric cancer. Our findings uncover a novel noncoding function for TET family proteins in facilitating gastric carcinogenesis. Cancer Res; 77(22); 6069-82. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28923852     DOI: 10.1158/0008-5472.CAN-16-2964

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.

Authors:  Hitoshi Itoh; Tsuyoshi Kadomatsu; Hironori Tanoue; Masaki Yugami; Keishi Miyata; Motoyoshi Endo; Jun Morinaga; Eisuke Kobayashi; Takeshi Miyamoto; Ryoma Kurahashi; Kazutoyo Terada; Hiroshi Mizuta; Yuichi Oike
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

Review 2.  Ten-eleven translocase: key regulator of the methylation landscape in cancer.

Authors:  Jyoti Shekhawat; Kavya Gauba; Shruti Gupta; Bikram Choudhury; Purvi Purohit; Praveen Sharma; Mithu Banerjee
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-28       Impact factor: 4.553

Review 3.  Mechanisms that regulate the activities of TET proteins.

Authors:  Kanak Joshi; Shanhui Liu; Peter Breslin S J; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-15       Impact factor: 9.207

4.  Cross-tolerance: embryonic heat conditioning induces inflammatory resilience by affecting different layers of epigenetic mechanisms regulating IL6 expression later in life.

Authors:  Tali Rosenberg; Tatiana Kisliouk; Osher Ben-Nun; Tomer Cramer; Noam Meiri
Journal:  Epigenetics       Date:  2020-07-24       Impact factor: 4.528

5.  Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma.

Authors:  Yuying Liu; Hui Zhu; Zhenxue Zhang; Changchun Tu; Dongyuan Yao; Bin Wen; Ru Jiang; Xing Li; Pengfei Yi; Jiejie Zhan; Jiaping Hu; Jianwu Ding; Liping Jiang; Fanglin Zhang
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

6.  Ten-eleven translocation-2 affects the fate of cells and has therapeutic potential in digestive tumors.

Authors:  Feng Wang; Jing Zhang; Jian Qi
Journal:  Chronic Dis Transl Med       Date:  2020-01-08

Review 7.  Epigenetic Regulations in Neural Stem Cells and Neurological Diseases.

Authors:  Hang Zhou; Bin Wang; Hao Sun; Xingshun Xu; Yongxiang Wang
Journal:  Stem Cells Int       Date:  2018-03-18       Impact factor: 5.443

Review 8.  The role of histone methylation in the development of digestive cancers: a potential direction for cancer management.

Authors:  Yuan Chen; Bo Ren; Jinshou Yang; Huanyu Wang; Gang Yang; Ruiyuan Xu; Lei You; Yupei Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-08-03

9.  TET2 inhibits tumorigenesis of breast cancer cells by regulating caspase-4.

Authors:  Xuguo Zhu; Shuangqi Li
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

10.  miR-26 Induces Apoptosis and Inhibits Autophagy in Non-small Cell Lung Cancer Cells by Suppressing TGF-β1-JNK Signaling Pathway.

Authors:  Yi He; Hao Liu; Lianyong Jiang; Bi Rui; Ju Mei; Haibo Xiao
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.